Zurich Cantonal Bank’s Immunovant IMVT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $209K | Hold |
13,044
| – | – | ﹤0.01% | 2115 |
|
|
2025
Q1 | $223K | Buy |
13,044
+5,200
| +66% | +$88.9K | ﹤0.01% | 2044 |
|
|
2024
Q4 | $194K | Sell |
7,844
-81
| -1% | -$2.01K | ﹤0.01% | 2167 |
|
|
2024
Q3 | $226K | Hold |
7,925
| – | – | ﹤0.01% | 2039 |
|
|
2024
Q2 | $209K | Sell |
7,925
-5
| -0.1% | -$132 | ﹤0.01% | 2022 |
|
|
2024
Q1 | $256K | Sell |
7,930
-2,440
| -24% | -$78.8K | ﹤0.01% | 1910 |
|
|
2023
Q4 | $437K | Buy |
10,370
+951
| +10% | +$40.1K | ﹤0.01% | 1592 |
|
|
2023
Q3 | $362K | Sell |
9,419
-281
| -3% | -$10.8K | ﹤0.01% | 1598 |
|
|
2023
Q2 | $184K | Buy |
9,700
+3,780
| +64% | +$71.7K | ﹤0.01% | 1985 |
|
|
2023
Q1 | $91.8K | Sell |
5,920
-1,372
| -19% | -$21.3K | ﹤0.01% | 2332 |
|
|
2022
Q4 | $129K | Sell |
7,292
-784
| -10% | -$13.9K | ﹤0.01% | 2111 |
|
|
2022
Q3 | $45K | Hold |
8,076
| – | – | ﹤0.01% | 2626 |
|
|
2022
Q2 | $31K | Hold |
8,076
| – | – | ﹤0.01% | 2714 |
|
|
2022
Q1 | $44K | Buy |
8,076
+2,445
| +43% | +$13.3K | ﹤0.01% | 2550 |
|
|
2021
Q4 | $48K | Sell |
5,631
-120
| -2% | -$1.02K | ﹤0.01% | 2751 |
|
|
2021
Q3 | $50K | Sell |
5,751
-6
| -0.1% | -$52 | ﹤0.01% | 2612 |
|
|
2021
Q2 | $61K | Buy |
5,757
+52
| +0.9% | +$551 | ﹤0.01% | 2403 |
|
|
2021
Q1 | $92K | Buy |
5,705
+1,221
| +27% | +$19.7K | ﹤0.01% | 2187 |
|
|
2020
Q4 | $207K | Buy |
4,484
+928
| +26% | +$42.8K | ﹤0.01% | 1819 |
|
|
2020
Q3 | $125K | Buy |
+3,556
| New | +$125K | ﹤0.01% | 1881 |
|